Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Vera Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Friedman Institute Releases Report on " Analysis on Libyan Oil and Gas Supply - Italy's Strategic Role in Mediterranean Energy "
-
Friedman Institute Releases Report on " Analysis on Libyan Oil and Gas Supply - Italy's Strategic Role in Mediterranean Energy "
-
Blue Star Families Applauds the Unveiling of Landmark NDAA to Make Critical Improvement in Lives of Military Families
-
Teekay Group Announces Changes to Boards of Directors
-
Avance Gas Holding Ltd: Successfully completed the eighth VLGC delivery to BW LPG
-
Nurix Therapeutics Presents New Positive Data from Phase 1a/1b Clinical Trial of NX-5948 in Chronic Lymphocytic Leukemia at the 66th American Society of Hematology Annual Meeting
-
Recursion Reports Interim Phase 1 Clinical Data for REC-617 Monotherapy, a Potential Best-in-Class CDK7 Inhibitor, With Encouraging Patient Response and Favorable Tolerability
-
Aramis Group - Declaration of transactions on own shares conducted from Dec 2 to Dec 6, 2024
-
Bitfarms Announces Restatement of Previously Issued Financial Statements
-
Odronextamab ASH Presentations Underscore Impressive Potential in Earlier Lines of Treatment and Additional Types of Lymphoma
-
TScan Therapeutics to Present Updated Data from the Ongoing ALLOHA™ Phase 1 Heme Trial During Oral Session at the 66th American Society of Hematology Annual Meeting and Exposition
-
Aramis Group - Declaration of transactions on own shares conducted from Nov 25 to Nov 29, 2024
-
Streamline Health® To Report Fiscal Third Quarter 2024 Financial Performance
-
Remilia Corporation launches massively anticipated CULT memecoin
-
Millicom (Tigo) share repurchase activity
-
Ashland rings opening bell at NYSE recognizes 100-year anniversary
-
Ashland rings opening bell at NYSE recognizes 100-year anniversary
-
Onex Corporation Announces Exemptive Relief in Substantial Issuer Bid
-
DR. JEAN MINER NAMED GUTHRIE’S FIRST CHIEF ACADEMIC OFFICER
-
Hurricane Helene: The Young Adults Helping Communities Recover
-
Fitch Ratings Upgrades GCC’s Credit Rating to ‘BBB’
-
Serve Robotics Announces Appointment of Lily Sarafan to its Board of Directors
-
Solomon Partners Hires Arik Rashkes as a Partner and Group Head to Launch Firm’s Financial Institutions Group
-
Alta Copper Invites Individual and Institutional Investors, as Well as Advisors and Analysts, to Attend Online at VirtualInvestorConferences.com
-
CENGN to Bolster Innovation through Living Labs with Federal Investment in Advanced Infrastructure
-
Harbert Management Corporation included in the 2024 Pensions & Investments Best Places to Work in Money Management
-
Coherent Announces General Availability of Industrial Temperature Range 100G ZR QSFP28-DCO
-
Toll Brothers Reports FY 2024 Results
-
Japan Smaller Capitalization Fund, Inc. Declares $0.3118 Ordinary Income Distribution
-
Greif Launches New Modular Packaging Solution
-
Roche commences tender offer for all shares of Poseida Therapeutics, Inc. for $9.00 per share in cash, plus a non-tradeable contingent value right for up to $4.00 per share in cash
-
Harbert Management Corporation included in the 2024 Pensions & Investments Best Places to Work in Money Management
-
Krystal Biotech Provides Update on EMA’s Ongoing Regulatory Review of B-VEC for Dystrophic Epidermolysis Bullosa
-
Tim Keating Joins AMD as Senior Vice President, Government Relations and Regulatory Affairs
-
NANOBIOTIX Announces Completion of Phase 1 Study of NBTXR3 (JNJ-1900) in Pancreatic Cancer
-
Verrica Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
-
Compass Diversified to Host Investor Day on January 16, 2025, in New York City
-
Lee Enterprises and ProRata.ai Announce Groundbreaking Content Partnership to Revolutionize Local News and Advertising
-
Oil-Dri Announces Record Results for the First Quarter of Fiscal Year 2025
-
Gaming Industry Visionary Bonnie Ross Joins Duolingo Board of Directors
-
Relay Therapeutics to Present Updated Clinical Data on RLY-2608 in HR+/HER2- Breast Cancer at 2024 San Antonio Breast Cancer Symposium
-
Oncocyte to Participate in “J.P. Morgan Week” and Host Investor Meetings
-
Myriad Genetics to Present New Data at San Antonio Breast Cancer Symposium
-
Fluence Energy, Inc. Announces Convertible Notes Offering and Intention to Enter into Capped Call Transactions
-
LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
HealthEquity Reports Third Quarter Ended October 31, 2024 Financial Results
-
Protara Announces Proposed Public Offering
-
Chimerix to Submit Dordaviprone for Accelerated Approval to U.S. FDA for Patients with Recurrent H3 K27M-Mutant Diffuse Glioma Before Year-End
-
Biomea Fusion Announces Preliminary Data from Ongoing COVALENT-103 Study of Investigational Covalent FLT3 Inhibitor BMF-500 in Relapsed or Refractory Acute Leukemia
